Cross Country医疗保健有 CCRN 深 沪
已收盘 08-01 16:00:00 美东时间
13.04
-0.410
-3.05%
华盛通- 最 高13.51
- 今 开13.32
- 成交量 29.30万股
- 最 低 12.85
- 昨 收 13.45
- 总市值 4.27亿
- 52周最高 18.33
- 市盈率 静 --
- 换手率 0.89%
- 52周最低 9.58
- 委 比 90.58%
- 总股本 3278.32万
- 历史最高 40.12
- 量 比 0.95
- 振 幅 4.91%
- 历史最低 3.76
- 每 手 1
- 风险率 3.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Fulgent Genetics Earnings Preview
Fulgent Genetics (NASDAQ:FLGT) will release its quarterly earnings report on Fr...
08-01 01:03
Cross Country Healthcare drops amid news of FTC meeting next week
Cross Country Healthcare (CCRN) declined 5.7% after the Federal Trade Commission announced it would be holding a closed-door meeting on Tuesday. While the exact subject of the meeting wasn't disclosed...
07-30 22:54
CareCloud Announces Preferred Stock Dividend Payments
CareCloud, Inc. announced that its Board of Directors has declared monthly cash dividends for its 8.75% Series A and Series B Cumulative Redeemable Perpetual Preferred Stock for July, August, and September 2025. The monthly dividend per share for both Series A and Series B Preferred Stock is $0.18229, with an additional payment of $0.04688 per share for Series A. Dividends are payable on August 15, September 15, and October 15, 2025, with record ...
07-25 12:00
美股大行评级 | 潜在涨幅261.01%！瑞穗上调Immuneering目标价至10美元，维持"跑赢大市"评级
康托·菲茨杰拉德：维持Meta Platforms(META)"超配"评级，目标价从676美元升至807美元
06-19 09:23
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
06-18 09:46
Barrington Research Maintains Market Perform on Cross Country Healthcare, Maintains $18.61 Price Target
Barrington Research analyst Kevin Steinke maintains Cross Country Healthcare (NASDAQ:CCRN) with a Market Perform and maintains $18.61 price target.
06-18 01:32
美股大行评级 | 潜在涨幅158.9%！蒙特利尔银行上调Disc Medicine目标价至120美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从112美元升至120美元</p> <p>• 巴克莱：维持Karyopharm Therapeutics(KPTI)"超配"评级，目标价从5美
05-14 08:48
UBS Maintains Neutral on Cross Country Healthcare, Lowers Price Target to $16.5
UBS analyst A.J. Rice maintains Cross Country Healthcare (NASDAQ:CCRN) with a Neutral and lowers the price target from $18.61 to $16.5.
05-14 00:34
Cross Country Healthcare Q1 Adj. EPS $0.06, Inline, Sales $293.41M Miss $305.48M Estimate
Cross Country Healthcare (NASDAQ:CCRN) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is a 68.42 percent decrease over earnings of $0.19 per share from the same period last
05-08 04:36
